Discovering And Developing New Cancer Treatments
Time & Location
About the Event
This talk will describe the general approaches to identifying and developing a new treatment and the investigation of new treatments based on blocking AMACR function, illustrating these approaches. This work has been funded by Prostate Cancer UK, Cancer Research UK and others.
Matthew Lloyd read Biological Chemistry at the University of Leicester, followed by a DPhil (PhD) degree at the University of Oxford working on antibiotics and finishing in 1992. After several years of working as a post-doctoral researcher at Brown University, USA and Oxford, Matthew joined the Department of Pharmacy & Pharmacology at the University of Bath in 2002. He is currently a Senior Lecturer in the Department. His research focusses on enzymes using techniques from chemistry, biochemistry and molecular biology to understand disease states and develop new treatments, especially for cancer.’